Randomized controlled trial showed no effect of probiotics on stool iron or serum ferritin in infants, suggesting limited efficacy in addressing iron deficiency.
Background: Lactobacillus probiotics may enhance host iron bioavailability, offering a potential strategy to address iron deficiency; however, evidence of such effects in infants is lacking. Objective: To examine whether neonatal administration of Lactiplantibacillus plantarum ATCC 202195 (LP202195), with or without fructooligosaccharide (FOS), reduces stool iron content and improves iron status in young infants in Dhaka, Bangladesh. Methods: This study was a secondary analysis of a randomized placebo-controlled trial in which infants, 0-4 days of age, were randomly allocated to one of five groups: placebo, 1- or 7-day regimens of LP202195, with or without FOS. Fecal iron was quantified in stool samples collected at 14 days postnatal age (n=307) and serum ferritin concentration was measured at 2 months postnatal age (n= 251). Effects of the 1- and 7-day LP202195 regimens were estimated using linear regression and reported as mean percent differences relative to placebo, with 95% confidence intervals (95%CI). Results: In the combined analysis irrespective of FOS co-administration, there were no differences in fecal iron concentrations following 1-day (% difference=9.8%, 95%CI: -19%, 49%; P=0.54) or 7-days (% difference= -6.1%, 95%CI: -31%, 28%; P=0.69) of LP202195 administration, relative to placebo (geometric mean concentration=4.3mg Fe/100g dry stool (95%CI:3.3, 5.6); n=53). There were no effects of LP202195 administration on serum ferritin concentration following the 1-day (% difference=2.4%, 95%CI: -22%, 35%; P=0.86) or 7-day (% difference=1%, 95% CI: -23%, 33%; P=0.94) regimen, relative to placebo (geometric mean concentration=189 ng/mL (95%CI: 155, 232); n=55). Inferences were unchanged when intervention groups were disaggregated by FOS co-administration (P>0.05 for all). Conclusions: LP202195, when administered neonatally as a probiotic alone or synbiotic with FOS for 1 or 7 days, did not affect stool iron (2 weeks of age) or iron status (2 months of age) in Dhaka, Bangladesh.
No takes yet. Share an insight, caveat, or question.
Roth et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: